Home › Pricey successor overtakes $1,000-per-pill hepatitis C drug
 

Keywords :   


Pricey successor overtakes $1,000-per-pill hepatitis C drug

2015-07-13 10:00:43| Biotech - Topix.net

Harvoni, the newest pill from California-based Gilead Sciences, accounted for more than three-fourths of the prescriptions ... . This image provided by Gilead Sciences shows a bottle of the Hepititis drug Harvoni.

Tags: drug successor hepatitis pricey

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
More »